Down‐regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α–kinoid
Bernard Lauwerys(UCLouvain), Frédéric Houssiau(Cliniques Universitaires Saint-Luc), É. Hachulla(Université de Lille), Géraldine Grouard-Vogel(Neovacs (France)), Xavier Mariette(Inserm), Christian Jørgensen(Inserm), Edwige Haelterman, Pierre Vandepapelière(Neovacs (France)), Estibaliz Lazaro(Centre National de la Recherche Scientifique), Olivier Dhellin(Neovacs (France)), B Fanget(Neovacs (France)), François Spertini(University Hospital of Lausanne)
Cited by 168
Related Papers
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
|New England Journal of Medicine|2009|857
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial
|Stem Cells Translational Medicine|2016|493